The Use of Cannabidiol Suppositories for Sexual Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorLondon Metropolitan University
About this trial
Research aim: To determine how cannabidiol suppositories might reduce sexual pain during intimacy. Outcomes are also hoped to increase sexual functioning, well-being, and quality of life.
Research intention: If cannabidiol suppository intervention reduces sexual pain and increases general well-being, then this research would be repeated on a larger scale, targeting psychosexual services.
A brief overview of the intervention:
Quantitatively, randomisation of cannabidiol suppositories will be into dose-specific groups. The intervention will be delivered over a period of one month, with follow-up scheduled at 12 weeks. Qualitatively, participants were asked approximately eight open-ended feedback questions throughout the study.
Eligibility criteria
Qualifiers
Has previously used cannabidiol in any capacity and has not experienced any allergic reaction
Is experiencing sexual pain
There will be an absence of co occurring difficulties
Has attempted sexual intercourse in the last month
Disqualifiers
Has not attempted sexual intercourse in the last month
Has co occurring difficulties
Aged below 18 years old
Are not experiencing sexual pain
Trial design
Treatments tested in this trial
- Cannabidiol suppository intervention 1
- Cannabidiol suppository intervention 2
- Cannabidiol suppository intervention 3
- Non cannabidiol group control
Treatment groups
50 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov